Cipla’s Vice Chairman MK Hamied resigns citing ‘age and health’, his son Kamil Hamied to join the board

In his resignation letter, MK Hamied said, “These past 47 years at Cipla have been truly a remarkable chapter in my life. Over the decades, I have seen the Company grow and evolve in ways I am immensely proud of.”

Cipla, appointment, vice chairman, board members, healthcare sector, pharma
Cipla announced that its Vice Chairman and Non-Executive Director MK Hamied has resigned from the company. (Image Credits: Reuters)

Cipla announced that its Vice Chairman and Non-Executive Director MK Hamied has resigned from the company, with effect from October 29, due to his age and health. In a regulatory filing, the company said, “Mr MK Hamied, vide letter dated 3rd September 2024, has resigned from the position of Vice Chairman and Non-Executive Director of the Company w.e.f. close of business hours of 29th October 2024 due to age and health.”

In his resignation letter, MK Hamied said, “These past 47 years at Cipla have been truly a remarkable chapter in my life. Over the decades, I have seen the Company grow and evolve in ways I am immensely proud of. I have had the good fortune of working with several key employees and Board members, and especially with Dr YK Hamied, who has been the guiding light of Cipla. He has greatly contributed towards making my journey at Cipla, one of the most rewarding experiences of my life.”

“I would like to express my deepest gratitude to all my fellow Board members for their unwavering support and guidance. I wish Cipla continued success in the future, and I hope to see its purpose of ‘Caring for Life’ at the heart of everything that it does,” he added.

Meanwhile, Cipla said that the board has approved the appointment of Kamil Hamied as Non-Executive Director, with effect November 1, 2024.

“I am pleased to see that Kamil Hamied will be joining the Board as a Non-Executive Director to maintain continuity while representing the promoter family,” MK Hamied said. 

Additionally, the board of Cipla also approved the appointment of Adil Zainulbhai and Abhijit Joshi as Additional Directors (Non- Executive) of the company with effect from 3rd September 2024. Further, Sharmila Paranjpe is also appointed as an Independent Director for a period of five years, effective 1st September 2024; and Maya Hari as an Independent Director for a period of five years with effect from 1st November 2024.

Get live Share Market updates, Stock Market Quotes, and the latest India News and business news on Financial Express. Download the Financial Express App for the latest finance news.

This article was first uploaded on September four, twenty twenty-four, at forty-three minutes past ten in the morning.
Market Data
Market Data